Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GLAXF save search
Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting
Published: 2022-03-21 (Crawled : 01:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 4.8%
H: 4.09%
C: 4.09%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K
|
Health Technology
|
| O: 10.34%
H: 0.0%
C: 0.0%
zejula pos positive results positive results phase 3 primec
GSK and Vir Biotechnology Announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment
Published: 2021-11-17 (Crawled : 12:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.43%
H: 2.31%
C: 2.27%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 9.97%
H: 4.0%
C: -6.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
covid treatment biotech technology iot covid-19
CureVac veröffentlicht in „Nature” präklinische Daten des COVID-19-Kandidaten der zweiten Generation, CV2CoV, die vergleichbaren Antikörperspiegel wie bei lizenziertem mRNA-Impfstoff nachweisen
Published: 2021-11-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -6.25%
H: 3.09%
C: -0.45%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.66%
H: 0.24%
C: -0.12%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 8.03%
H: 4.75%
C: 2.8%
covid cv2cov
Diabetes Drugs Global Market Report 2022: Featuring AstraZeneca, Eli Lilly, GlaxoSmithKline, Merck, Pfizer & More
Published: 2023-03-22 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 5.54%
H: 0.96%
C: 0.96%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.81%
H: 0.51%
C: 0.51%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.08%
H: 0.34%
C: -0.03%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.69%
H: 0.11%
C: -0.76%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.02%
H: 1.34%
C: 0.53%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 6.53%
H: 0.56%
C: -0.54%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.56%
H: 0.34%
C: -0.52%
report global diabetes market
Primary endpoint met in COMET-TAIL Phase 3 trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -0.31%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.93%
H: 0.0%
C: 0.0%
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
covid treatment phase 3 trial
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Topical Corticosteroids Market to Grow by USD 1.08 billion between 2022 to 2027, globally at 4% CAGR - Technavio
Published: 2024-01-30 (Crawled : 23:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: 4.34%
H: 0.0%
C: 0.0%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 0.0%
H: 1.38%
C: 0.26%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
market
Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation - Technavio
Published: 2024-02-02 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -3.89%
H: 0.0%
C: 0.0%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -4.76%
H: 7.0%
C: 3.18%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.05%
H: 0.59%
C: 0.27%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
million heart therapeutics growth market
Worldwide Elderly Nutrition Industry to 2026 - Development of Innovative Micronutrient-rich Food Presents Opportunities
Published: 2021-10-20 (Crawled : 14:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.07%
H: 2.35%
C: 1.61%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.2%
H: 0.75%
C: 0.54%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.23%
H: 2.34%
C: 1.74%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 3.51%
H: 1.03%
C: -0.18%
KHC | $37.78 1.81% 1.77% 9.1M
|
Consumer Non-Durables
|
| O: -0.19%
H: 0.84%
C: 0.49%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.37%
H: 0.65%
C: -0.3%
food nutrition
CureVac verlagert Fokus der COVID-19-Impfstoffentwicklung auf mRNA-Technologie der zweiten Generation
Published: 2021-10-12 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.38%
H: 0.0%
C: -5.75%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.51%
H: 0.15%
C: -1.43%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -13.04%
H: 13.08%
C: 9.7%
covid covid-19
North America Human Papillomavirus Vaccine Market to Reach $2.96 Billion by 2028 at a CAGR of 4.7%
Published: 2022-11-30 (Crawled : 19:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 4.49%
H: 4.82%
C: 3.08%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.64%
H: 2.88%
C: 2.88%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.61%
H: 1.22%
C: 0.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.96%
H: 0.0%
C: 0.0%
america vaccine market
Global Drug Delivery Devices Market Research Report (2021 to 2026) - by Route of Administration, Vehicles, Application, End-user and Region
Published: 2022-01-04 (Crawled : 17:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.82%
H: 1.65%
C: 0.04%
WST | $372.04 -1.4% 0.0% 440K
|
Health Technology
|
| O: -0.79%
H: 0.66%
C: -3.03%
PANA 4 | $10.25 0.0% 110K
|
Finance
|
| O: 0.72%
H: 0.0%
C: -0.72%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.23%
H: 0.62%
C: -0.07%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.13%
H: 1.18%
C: 1.17%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: 0.1%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.03%
H: 0.0%
C: 0.0%
OSUR | $5.27 0.38% 0.38% 660K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 2.92%
H: 2.2%
C: -1.17%
ATRS | $5.59 0.0%
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: -2.51%
application drug device research liver vehicles drug delivery
CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-16 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 2.85%
C: 2.85%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.69%
H: 0.27%
C: -0.75%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: -2.73%
H: 5.99%
C: 4.08%
Health and Wellness Food Market Size to Grow by USD 452.93 million From 2022 to 2027, Assessment on Parent Market, Five Forces Analysis, Market Dynamics & Segmentation - Technavio
Published: 2022-11-16 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 0.0%
H: 2.85%
C: 2.85%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.69%
H: 0.27%
C: -0.75%
health food market
CureVac veröffentlicht am 16. November 2022 Finanzergebnisse des dritten Quartals sowie der ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-10 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 3.14%
H: 2.63%
C: 1.94%
Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -1.66%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.03%
H: 0.38%
C: 0.25%
ZNTL | $12.97 3.43% 3.32% 1M
|
Health Technology
|
| O: 2.59%
H: 4.49%
C: 4.23%
pharmaceuticals financial results
Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: -2.65%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.21%
C: -0.01%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.05%
H: 1.44%
C: 1.15%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 2.58%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: 0.0%
rare disease cell eye market
CureVac berichtet über Fortschritt im Verfahren der Verletzung geistigen Eigentums gegen BioNTech in Deutschland
Published: 2023-09-28 (Crawled : 11:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -3.04%
H: 2.1%
C: 2.1%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.94%
H: 0.44%
C: -0.95%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 2.53%
H: 1.99%
C: -10.84%
Cancer Supportive Care Market Size to Grow by USD 4.98 Billion | Market Research Insights Highlight Growing Prevalence of Cancer Cases as Key Driver | Technavio
Published: 2022-02-01 (Crawled : 05:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.45%
H: 0.53%
C: 0.42%
BAX | $39.47 -0.45% 0.0% 2.8M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -0.77%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.39%
H: 0.24%
C: 0.19%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.22%
H: 0.91%
C: 0.68%
research cancer growing
Tendonitis Treatment Market Size Worth $235.4 Billion By 2028: Grand View Research, Inc.
Published: 2021-10-07 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.4%
H: 0.1%
C: 0.1%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.42%
H: 1.4%
C: 0.97%
treatment research
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.